Top
GLP2R has not been detected as a mutational cancer driver

GLP2R
Ensembl id ENSG00000065325
Mutated samples
Coding Sequence 83 (1.2%)
Protein Affecting 59 (0.9%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all GLP2R gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 35 24 6.50
Lung adenocarcinoma No 10 8 2.05
Lung squamous cell carcinoma No 6 5 2.87
Head and neck squamous cell carcinoma No 5 4 1.07
Small cell lung carcinoma No 3 3 4.35
Breast carcinoma No 3 2 0.17
Renal clear cell carcinoma No 2 2 0.48
Uterine corpus endometrioid carcinoma No 3 2 0.87
Stomach adenocarcinoma No 4 2 1.24
Glioblastoma multiforme No 3 2 0.53
Prostate adenocarcinoma No 1 1 0.41
Thyroid carcinoma No 1 1 0.31
Non small cell lung carcinoma No 1 1 3.23
Lower grade glioma No 1 1 0.59
Serous ovarian adenocarcinoma No 2 1 0.32
Chronic lymphocytic leukemia No 1 0 0.00
Colorectal adenocarcinoma No 1 0 0.00
Diffuse B cell lymphoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence